Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial
2025 · Infectious Diseases of Poverty · 3 citations
https://doi.org/10.1186/s40249-025-01290-z